US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

46.35

-0.5900-1.26%

Post-market: 46.350.00000.00%18:10 EDT

Volume:2.71M

Turnover:126.39M

Market Cap:27.03B

PE:26.02

High:47.33

Open:47.00

Low:46.06

Close:46.94

52wk High:47.86

52wk Low:29.66

Shares:583.17M

Float Shares:379.85M

Volume Ratio:0.64

T/O Rate:0.71%

Dividend:0.88

Dividend Rate:1.90%

EPS(TTM):1.78

EPS(LYR):1.78

ROE:13.20%

ROA:5.15%

PB:4.17

PE(LYR):26.02

Loading ...

Overview Company News Filings

Royalty Pharma; EVP & CFO Terrance P. Coyne reports common share disposal valued at $1,583,000

How Royalty Pharma’s New AI and Dealmaking Hires Could Shape RPRX’s Royalty Sourcing Strategy

Simply Wall St.

Press Release: Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence

S&P 500 Futures Decline In Premarket Trading; Super Micro Computer, Royalty Pharma Lag

Press Release: Royalty Pharma Announces Expansion of Leadership Team

Royalty Pharma EVP and CFO Terrance P. Coyne Disposes of Common Shares

Press Release: Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

Zymeworks Q4 Net Loss Widens, Revenue Falls; Enters $250 Million Financing Agreement with Royalty Pharma

MT Newswires Live

Zymeworks, Royalty Pharma enter $250M royalty-backed note financing

Canada's Zymeworks 2025 revenue rises 39%

Zymeworks and Royalty Pharma Enter Into $250 Million Royalty-Backed Note Financing

THOMSON REUTERS

Zymeworks Inc - Co to Retain 70% of Ziihera Royalties

THOMSON REUTERS

Zymeworks Secures $250 Million Royalty-Backed Note Financing From Royalty Pharma

Zymeworks FY 2025 revenue rises 39% to USD 106.0 million

Royalty Pharma to Join Fireside Chat at TD Cowen 46th Annual Health Care Conference

Royalty Pharma EVP and CFO Terrance P. Coyne Disposes of Common Shares

RevMed Q4 net loss widens to USD 364.9 million (87.5%)

BRAIN Biotech posts Q1 net loss of EUR 2.9 million, revenue down 9% to EUR 11.9 million

PTC Therapeutics posts FY 2025 total revenues of USD 1.73B2.15x

Royalty Pharma plc Publishes Q4 2025 Financial Results Call Transcript

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RPRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RPRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","market":"US","secType":"STK","nameCN":"Royalty Pharma plc","latestPrice":46.35,"timestamp":1774641600000,"preClose":46.94,"halted":0,"volume":2710159,"hourTrading":{"tag":"盘后","latestPrice":46.35,"preClose":46.35,"latestTime":"18:10 EDT","volume":76495,"amount":3549717.658,"timestamp":1774649412896,"change":0,"changeRate":0,"amplitude":0.00589},"delay":0,"changeRate":-0.012569237324243638,"floatShares":379849980,"shares":583174298,"eps":1.781403,"marketStatus":"Market Closed","change":-0.59,"latestTime":"03-27 16:00:00 EDT","open":46.995,"high":47.33,"low":46.06,"amount":126388218.892297,"amplitude":0.027056,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.781403,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1592280000000,"exchange":"NASDAQ","adjPreClose":46.94,"dividendRate":0.018986,"preHourTrading":{"tag":"盘前","latestPrice":47.26,"preClose":46.94,"latestTime":"09:20 EDT","volume":7472,"amount":350385.9904,"timestamp":1774617611010,"change":0.32,"changeRate":0.006817,"amplitude":0.01553},"postHourTrading":{"tag":"盘后","latestPrice":46.35,"preClose":46.35,"latestTime":"18:10 EDT","volume":76495,"amount":3549717.658,"timestamp":1774649412896,"change":0,"changeRate":0,"amplitude":0.00589},"volumeRatio":0.640336,"impliedVol":0.3079,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRX\",,,,,undefined,":{"symbol":"RPRX","floatShares":379849980,"roa":"5.15%","roe":"13.20%","lyrEps":1.781403,"volumeRatio":0.640336,"shares":583174298,"dividePrice":0.88,"high":47.33,"amplitude":0.027056,"preClose":46.94,"low":46.06,"week52Low":29.66,"pbRate":"4.17","psRate":"11.37","week52High":47.86,"institutionHeld":0.9297,"latestPrice":46.35,"eps":1.781403,"divideRate":0.018986,"volume":2710159,"delay":0,"ttmEps":1.781403,"open":46.995,"prevYearClose":38.64,"prevWeekClose":45.36,"prevMonthClose":46.21,"prevQuarterClose":38.64,"fiveDayClose":45.36,"twentyDayClose":46.21,"sixtyDayClose":38.99,"dividendPayoutRate":0.4905978045748245,"dividendFrequency":"Q","dividendGrowthYears":5,"dividendGrowthRate":0.047619047619047665,"fiveYearAvgDividendRate":0.02408439366820899},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RPRX\",params:#limit:5,,,undefined,":[{"date":"2026-02-20","symbol":"RPRX","amount":0.235,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-10","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-03-10"},{"market":"US","date":"2026-02-11","symbol":"RPRX","fiscalQuarterEnding":"2025/12","expectedEps":1.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"pre","actualEps":1.46},{"date":"2025-11-14","symbol":"RPRX","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-14","defaultRemindTime":1763130600000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-10","payableDate":"2025-11-14","currency":"USD","dateTimestamp":1763096400000,"payDate":"2025-12-10"},{"market":"US","date":"2025-11-05","symbol":"RPRX","fiscalQuarterEnding":"2025/09","expectedEps":1.11,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":1.17},{"date":"2025-08-15","symbol":"RPRX","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-15","defaultRemindTime":1755264600000,"name":"Royalty Pharma plc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-10","payableDate":"2025-08-15","currency":"USD","dateTimestamp":1755230400000,"payDate":"2025-09-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RPRX\",market:\"US\",,,undefined,":[{"executeDate":"2020-09-14","recordDate":"2020-09-15","paymentDate":"2020-09-30","value":0.15,"currency":"USD"},{"executeDate":"2020-11-19","recordDate":"2020-11-20","paymentDate":"2020-12-15","value":0.15,"currency":"USD"},{"executeDate":"2021-02-18","recordDate":"2021-02-19","paymentDate":"2021-03-15","value":0.17,"currency":"USD"},{"executeDate":"2021-05-19","recordDate":"2021-05-20","paymentDate":"2021-06-15","value":0.17,"currency":"USD"},{"executeDate":"2021-08-19","recordDate":"2021-08-20","paymentDate":"2021-09-15","value":0.17,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RPRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1770868800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RPRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RPRX","date":"2026-03-26","current":26.018818,"percent":0.501222,"low":9.420627,"twenty":15.379534,"median":26.092243,"eighty":56.189678,"high":536.452748,"avg":54.529275,"sd":101.407237,"marketCap":20148527322},"quantilePoints":[{"date":"2021-04-01","current":26.780274,"twenty":10.841764,"median":12.736219,"eighty":14.558244,"marketCap":26111838518},{"date":"2021-04-09","current":26.344418,"twenty":10.870271,"median":12.777628,"eighty":14.859728,"marketCap":25686860909},{"date":"2021-04-16","current":26.070451,"twenty":10.877008,"median":12.890883,"eighty":15.364506,"marketCap":25419732126},{"date":"2021-04-23","current":27.153866,"twenty":10.880637,"median":12.943264,"eighty":25.867466,"marketCap":26476105040},{"date":"2021-04-30","current":27.609843,"twenty":10.889966,"median":13.040871,"eighty":26.105319,"marketCap":26920701720},{"date":"2021-05-07","current":25.708529,"twenty":10.902405,"median":13.112851,"eighty":26.233724,"marketCap":25066844306},{"date":"2021-05-14","current":25.415982,"twenty":10.923137,"median":13.188745,"eighty":26.203698,"marketCap":24727692206},{"date":"2021-05-21","current":25.397262,"twenty":11.006583,"median":13.242152,"eighty":26.105319,"marketCap":24709478831},{"date":"2021-05-28","current":25.035336,"twenty":11.014357,"median":13.396752,"eighty":26.063326,"marketCap":24357353580},{"date":"2021-06-04","current":28.211553,"twenty":11.037163,"median":13.462808,"eighty":26.226114,"marketCap":27447556215},{"date":"2021-06-11","current":28.01811,"twenty":11.073444,"median":13.525947,"eighty":26.468948,"marketCap":27259351339},{"date":"2021-06-18","current":27.46898,"twenty":11.088992,"median":13.552567,"eighty":26.637064,"marketCap":26725092338},{"date":"2021-06-25","current":26.570403,"twenty":11.125544,"median":13.593515,"eighty":26.668197,"marketCap":25850850335},{"date":"2021-07-02","current":26.35824,"twenty":11.210793,"median":13.670814,"eighty":26.643499,"marketCap":25644432084},{"date":"2021-07-09","current":26.064954,"twenty":11.239817,"median":13.722576,"eighty":26.638351,"marketCap":25359089208},{"date":"2021-07-16","current":26.726929,"twenty":11.289271,"median":13.759358,"eighty":26.648439,"marketCap":26003137199},{"date":"2021-07-23","current":26.581925,"twenty":11.338048,"median":13.881632,"eighty":26.679943,"marketCap":25862059759},{"date":"2021-07-30","current":25.17802,"twenty":11.350107,"median":13.916375,"eighty":26.648439,"marketCap":24496173638},{"date":"2021-08-06","current":24.380496,"twenty":11.371465,"median":14.057313,"eighty":26.638351,"marketCap":23720247719},{"date":"2021-08-13","current":24.202628,"twenty":11.413966,"median":14.101803,"eighty":26.627102,"marketCap":23515781358},{"date":"2021-08-20","current":24.371352,"twenty":11.425707,"median":14.162722,"eighty":26.606281,"marketCap":23679717867},{"date":"2021-08-27","current":24.490085,"twenty":11.428044,"median":14.303845,"eighty":26.590141,"marketCap":23795080595},{"date":"2021-09-03","current":24.565073,"twenty":11.442485,"median":14.393216,"eighty":26.58299,"marketCap":23867941265},{"date":"2021-09-10","current":24.046401,"twenty":11.483683,"median":14.412385,"eighty":26.575012,"marketCap":23363988295},{"date":"2021-09-17","current":24.058899,"twenty":11.513281,"median":14.476137,"eighty":26.520738,"marketCap":23376131740},{"date":"2021-09-24","current":23.18403,"twenty":11.53978,"median":14.588573,"eighty":26.47642,"marketCap":22526090586},{"date":"2021-10-01","current":22.640362,"twenty":11.560125,"median":14.847176,"eighty":26.437867,"marketCap":21997850726},{"date":"2021-10-08","current":22.177931,"twenty":11.592778,"median":15.062517,"eighty":26.384717,"marketCap":21548543258},{"date":"2021-10-15","current":23.99016,"twenty":11.640462,"median":15.413014,"eighty":26.360183,"marketCap":23309342792},{"date":"2021-10-22","current":23.433993,"twenty":11.659417,"median":22.124814,"eighty":26.350751,"marketCap":22768959487},{"date":"2021-10-29","current":24.702553,"twenty":11.679854,"median":22.271667,"eighty":26.344954,"marketCap":24001519161},{"date":"2021-11-05","current":24.696304,"twenty":11.723704,"median":22.559124,"eighty":26.333991,"marketCap":23995447438},{"date":"2021-11-12","current":32.51009,"twenty":11.752375,"median":22.640362,"eighty":26.350751,"marketCap":25452734666},{"date":"2021-11-19","current":32.2309,"twenty":11.763977,"median":22.8872,"eighty":26.47642,"marketCap":25234152021},{"date":"2021-11-26","current":32.486824,"twenty":11.775219,"median":22.924694,"eighty":26.585121,"marketCap":25434519446},{"date":"2021-12-03","current":29.19859,"twenty":11.807468,"median":23.015305,"eighty":26.640925,"marketCap":22860101627},{"date":"2021-12-10","current":29.291653,"twenty":11.847383,"median":23.171532,"eighty":26.80037,"marketCap":22932962508},{"date":"2021-12-17","current":29.888809,"twenty":11.870433,"median":23.215276,"eighty":26.895847,"marketCap":23400486499},{"date":"2021-12-23","current":31.21496,"twenty":11.891419,"median":23.371502,"eighty":27.107873,"marketCap":24438754063},{"date":"2021-12-31","current":30.904749,"twenty":11.910529,"median":23.48711,"eighty":27.173363,"marketCap":24195884457},{"date":"2022-01-07","current":31.222715,"twenty":11.93171,"median":23.58397,"eighty":27.251023,"marketCap":24444825803},{"date":"2022-01-14","current":30.757399,"twenty":11.982869,"median":23.843307,"eighty":27.501351,"marketCap":24080521395},{"date":"2022-01-21","current":30.354125,"twenty":12.0166,"median":23.915171,"eighty":27.798092,"marketCap":23764790907},{"date":"2022-01-28","current":30.602294,"twenty":12.025032,"median":23.99016,"eighty":27.981993,"marketCap":23959086592},{"date":"2022-02-04","current":30.997812,"twenty":12.078439,"median":24.05265,"eighty":28.604645,"marketCap":24268745339},{"date":"2022-02-11","current":30.912504,"twenty":12.120603,"median":24.152635,"eighty":28.953331,"marketCap":24201956198},{"date":"2022-02-18","current":38.611798,"twenty":12.199308,"median":24.193255,"eighty":29.097649,"marketCap":23928812189},{"date":"2022-02-25","current":37.690836,"twenty":12.300501,"median":24.209173,"eighty":29.140126,"marketCap":23358066605},{"date":"2022-03-04","current":37.641849,"twenty":12.370773,"median":24.296364,"eighty":29.218581,"marketCap":23327707798},{"date":"2022-03-11","current":37.494887,"twenty":12.393263,"median":24.333858,"eighty":29.372308,"marketCap":23236631375},{"date":"2022-03-18","current":38.523621,"twenty":12.400806,"median":24.371352,"eighty":29.55223,"marketCap":23874166335},{"date":"2022-03-25","current":37.592862,"twenty":12.401989,"median":24.41822,"eighty":29.826979,"marketCap":23297348990},{"date":"2022-04-01","current":38.56281,"twenty":12.415244,"median":24.490085,"eighty":30.011342,"marketCap":23898453382},{"date":"2022-04-08","current":40.581088,"twenty":12.46803,"median":24.558469,"eighty":30.160243,"marketCap":25149236257},{"date":"2022-04-14","current":43.206807,"twenty":12.481269,"median":24.62444,"eighty":30.337063,"marketCap":26776468347},{"date":"2022-04-22","current":41.977613,"twenty":12.531575,"median":24.702553,"eighty":30.374674,"marketCap":26014702030},{"date":"2022-04-29","current":41.717726,"twenty":12.617931,"median":24.768168,"eighty":30.481311,"marketCap":25853642688},{"date":"2022-05-06","current":40.037043,"twenty":12.672923,"median":24.835282,"eighty":30.64107,"marketCap":24117113377},{"date":"2022-05-13","current":40.258799,"twenty":12.697537,"median":24.934608,"eighty":30.867524,"marketCap":24250692555},{"date":"2022-05-20","current":39.835446,"twenty":12.713191,"median":25.066536,"eighty":30.997812,"marketCap":23995677761},{"date":"2022-05-27","current":41.599415,"twenty":12.727345,"median":25.116457,"eighty":31.059854,"marketCap":25058239402},{"date":"2022-06-03","current":40.843428,"twenty":12.733261,"median":25.194498,"eighty":31.165326,"marketCap":24602855842},{"date":"2022-06-10","current":40.803109,"twenty":12.735627,"median":25.334861,"eighty":31.219613,"marketCap":24578568718},{"date":"2022-06-17","current":39.664089,"twenty":12.739177,"median":25.403502,"eighty":31.585662,"marketCap":23892457487},{"date":"2022-06-24","current":43.54482,"twenty":12.746867,"median":25.497104,"eighty":32.196777,"marketCap":26230093099},{"date":"2022-07-01","current":43.081148,"twenty":12.778811,"median":25.671953,"eighty":32.432537,"marketCap":25950791181},{"date":"2022-07-08","current":43.302904,"twenty":12.783544,"median":25.758729,"eighty":32.51009,"marketCap":26084370359},{"date":"2022-07-15","current":44.280647,"twenty":12.872277,"median":25.81215,"eighty":32.913364,"marketCap":26673333098},{"date":"2022-07-22","current":43.575059,"twenty":12.909488,"median":25.883655,"eighty":37.112786,"marketCap":26248308441},{"date":"2022-07-29","current":43.837135,"twenty":12.927331,"median":25.924329,"eighty":37.494887,"marketCap":26406174742},{"date":"2022-08-05","current":55.302721,"twenty":12.943264,"median":26.008185,"eighty":37.641849,"marketCap":25776487684},{"date":"2022-08-12","current":57.582574,"twenty":12.984673,"median":26.031171,"eighty":37.739824,"marketCap":26839122629},{"date":"2022-08-19","current":57.452297,"twenty":13.031997,"median":26.064954,"eighty":37.955368,"marketCap":26778400632},{"date":"2022-08-26","current":56.084385,"twenty":13.049744,"median":26.130056,"eighty":38.170912,"marketCap":26140819665},{"date":"2022-09-02","current":54.807667,"twenty":13.070449,"median":26.166685,"eighty":38.396254,"marketCap":25545744095},{"date":"2022-09-09","current":56.839993,"twenty":13.104371,"median":26.235626,"eighty":38.531459,"marketCap":26493007247},{"date":"2022-09-16","current":54.651334,"twenty":13.130841,"median":26.335729,"eighty":38.654091,"marketCap":25472877699},{"date":"2022-09-23","current":52.540842,"twenty":13.157825,"median":26.35824,"eighty":38.942952,"marketCap":24489181349},{"date":"2022-09-30","current":52.345426,"twenty":13.203924,"median":26.443047,"eighty":39.5308,"marketCap":24398098354},{"date":"2022-10-07","current":53.231312,"twenty":13.220789,"median":26.570403,"eighty":39.868964,"marketCap":24811007933},{"date":"2022-10-14","current":53.947837,"twenty":13.238217,"median":26.594475,"eighty":40.109618,"marketCap":25144978916},{"date":"2022-10-21","current":53.439755,"twenty":13.287126,"median":26.637064,"eighty":40.381773,"marketCap":24908163128},{"date":"2022-10-28","current":55.706581,"twenty":13.343344,"median":26.697563,"eighty":40.596976,"marketCap":25964725874},{"date":"2022-11-04","current":54.638307,"twenty":13.42205,"median":26.813768,"eighty":40.835364,"marketCap":25466805499},{"date":"2022-11-11","current":52.620617,"twenty":13.438915,"median":26.87804,"eighty":41.030913,"marketCap":26669181236},{"date":"2022-11-18","current":51.362611,"twenty":13.477144,"median":26.991976,"eighty":41.419994,"marketCap":26031598351},{"date":"2022-11-25","current":51.494402,"twenty":13.508626,"median":27.128959,"eighty":41.588023,"marketCap":26098392749},{"date":"2022-12-02","current":52.53675,"twenty":13.524865,"median":27.163206,"eighty":41.70117,"marketCap":26626675710},{"date":"2022-12-09","current":50.020737,"twenty":13.531271,"median":27.175694,"eighty":42.099572,"marketCap":25351509941},{"date":"2022-12-16","current":48.175661,"twenty":13.536595,"median":27.242334,"eighty":42.522809,"marketCap":24416388376},{"date":"2022-12-23","current":47.253123,"twenty":13.555525,"median":27.46898,"eighty":42.883467,"marketCap":23948827594},{"date":"2022-12-30","current":47.348971,"twenty":13.573322,"median":27.509444,"eighty":43.081148,"marketCap":23997405338},{"date":"2023-01-06","current":45.635686,"twenty":13.58452,"median":27.609843,"eighty":43.15977,"marketCap":23129078171},{"date":"2023-01-13","current":47.169255,"twenty":13.602481,"median":27.828632,"eighty":43.302904,"marketCap":23906322069},{"date":"2023-01-20","current":45.92323,"twenty":13.638343,"median":27.953974,"eighty":43.369326,"marketCap":23274811402},{"date":"2023-01-27","current":46.606148,"twenty":13.663787,"median":28.075391,"eighty":43.492269,"marketCap":23620927825},{"date":"2023-02-03","current":46.678034,"twenty":13.677842,"median":28.635778,"eighty":43.575059,"marketCap":23657361133},{"date":"2023-02-10","current":45.647667,"twenty":13.700329,"median":28.791441,"eighty":44.018571,"marketCap":23135150389},{"date":"2023-02-17","current":536.452748,"twenty":13.744823,"median":28.985327,"eighty":45.527856,"marketCap":22977344089},{"date":"2023-02-24","current":515.754518,"twenty":13.745207,"median":29.047283,"eighty":45.638082,"marketCap":22090797514},{"date":"2023-03-03","current":505.263634,"twenty":13.756547,"median":29.121037,"eighty":45.865721,"marketCap":21641451990},{"date":"2023-03-10","current":469.254386,"twenty":13.824571,"median":29.181811,"eighty":46.294641,"marketCap":20099103841},{"date":"2023-03-17","current":491.086765,"twenty":13.863361,"median":29.214845,"eighty":46.433622,"marketCap":21034228309},{"date":"2023-03-24","current":502.286492,"twenty":13.889221,"median":29.284382,"eighty":46.639695,"marketCap":21513935017},{"date":"2023-03-31","current":510.792614,"twenty":13.89653,"median":29.384716,"eighty":46.953597,"marketCap":21878269226},{"date":"2023-04-06","current":514.195062,"twenty":13.908662,"median":29.389187,"eighty":46.991936,"marketCap":22024002909},{"date":"2023-04-14","current":517.881048,"twenty":13.930103,"median":29.629008,"eighty":47.183633,"marketCap":22181881066},{"date":"2023-04-21","current":511.926763,"twenty":14.003344,"median":29.811522,"eighty":47.38731,"marketCap":21926847120},{"date":"2023-04-28","current":501.012305,"twenty":14.059562,"median":29.901277,"eighty":48.453621,"marketCap":21459359029},{"date":"2023-05-05","current":494.632691,"twenty":14.081953,"median":30.06718,"eighty":50.15732,"marketCap":21186107429},{"date":"2023-05-12","current":63.132216,"twenty":14.097435,"median":30.121467,"eighty":50.607807,"marketCap":20949289375},{"date":"2023-05-19","current":61.532363,"twenty":14.125705,"median":30.273353,"eighty":51.046312,"marketCap":20418037790},{"date":"2023-05-26","current":58.989098,"twenty":14.148386,"median":30.350248,"eighty":51.427308,"marketCap":19574116514},{"date":"2023-06-02","current":60.690707,"twenty":14.160754,"median":30.36188,"eighty":51.544722,"marketCap":20138754490},{"date":"2023-06-09","current":63.179081,"twenty":14.184848,"median":30.416167,"eighty":52.19192,"marketCap":20964461638},{"date":"2023-06-16","current":58.915911,"twenty":14.243506,"median":30.482087,"eighty":52.539205,"marketCap":19549831009},{"date":"2023-06-23","current":56.738584,"twenty":14.315085,"median":30.602294,"eighty":52.629752,"marketCap":18827337255},{"date":"2023-06-29","current":54.158725,"twenty":14.348803,"median":30.610049,"eighty":52.716465,"marketCap":17971273226},{"date":"2023-07-07","current":55.787147,"twenty":14.368253,"median":30.7225,"eighty":53.147934,"marketCap":18511625698},{"date":"2023-07-14","current":56.189678,"twenty":14.385627,"median":30.817667,"eighty":53.439755,"marketCap":18645195972},{"date":"2023-07-21","current":57.031334,"twenty":14.406989,"median":30.912504,"eighty":53.523133,"marketCap":18924479272},{"date":"2023-07-28","current":56.720287,"twenty":14.411846,"median":30.997812,"eighty":53.911359,"marketCap":18821265879},{"date":"2023-08-04","current":55.970115,"twenty":14.415735,"median":31.028834,"eighty":54.260503,"marketCap":18572339459},{"date":"2023-08-11","current":72.162914,"twenty":14.43566,"median":31.102508,"eighty":54.461129,"marketCap":18397718410},{"date":"2023-08-18","current":69.094161,"twenty":14.479538,"median":31.168428,"eighty":54.648729,"marketCap":17615348965},{"date":"2023-08-25","current":69.778729,"twenty":14.509418,"median":31.203327,"eighty":54.763373,"marketCap":17789877534},{"date":"2023-09-01","current":70.392479,"twenty":14.580141,"median":31.269247,"eighty":54.978425,"marketCap":17946351423},{"date":"2023-09-08","current":68.126323,"twenty":14.602628,"median":31.455373,"eighty":55.107305,"marketCap":17368601679},{"date":"2023-09-15","current":67.890265,"twenty":14.667652,"median":31.928445,"eighty":55.289693,"marketCap":17308419414},{"date":"2023-09-22","current":61.988816,"twenty":14.847176,"median":32.246411,"eighty":55.641442,"marketCap":15803862789},{"date":"2023-09-29","current":63.216318,"twenty":14.859728,"median":32.339474,"eighty":55.973774,"marketCap":16116810567},{"date":"2023-10-06","current":62.767808,"twenty":15.016671,"median":32.482946,"eighty":56.080794,"marketCap":16002464263},{"date":"2023-10-13","current":63.971703,"twenty":15.066953,"median":32.556622,"eighty":56.189678,"marketCap":16309393815},{"date":"2023-10-20","current":66.355888,"twenty":15.150362,"median":32.773769,"eighty":56.544637,"marketCap":16917234691},{"date":"2023-10-27","current":64.32579,"twenty":15.218983,"median":32.928874,"eighty":56.599178,"marketCap":16399667212},{"date":"2023-11-03","current":64.868723,"twenty":16.726003,"median":36.907039,"eighty":56.712968,"marketCap":16538086422},{"date":"2023-11-10","current":88.80003,"twenty":21.996708,"median":37.21566,"eighty":56.826842,"marketCap":16375613449},{"date":"2023-11-17","current":85.949098,"twenty":22.092944,"median":37.494887,"eighty":56.889499,"marketCap":15849873215},{"date":"2023-11-24","current":87.765402,"twenty":22.177931,"median":37.592862,"eighty":57.067927,"marketCap":16184817745},{"date":"2023-12-01","current":65.305922,"twenty":22.190429,"median":37.666342,"eighty":57.217798,"marketCap":12043065075},{"date":"2023-12-08","current":69.407144,"twenty":22.271667,"median":37.730026,"eighty":57.452297,"marketCap":12799371342},{"date":"2023-12-15","current":69.069396,"twenty":22.390399,"median":37.75452,"eighty":57.77799,"marketCap":12737087296},{"date":"2023-12-22","current":66.053792,"twenty":22.540377,"median":37.955368,"eighty":58.915911,"marketCap":12180979747},{"date":"2023-12-29","current":67.453032,"twenty":22.562873,"median":37.997597,"eighty":59.09156,"marketCap":12439013650},{"date":"2024-01-05","current":67.067035,"twenty":22.579121,"median":38.02395,"eighty":59.439201,"marketCap":12367831884},{"date":"2024-01-12","current":69.021146,"twenty":22.595368,"median":38.190507,"eighty":60.273538,"marketCap":12728189575},{"date":"2024-01-19","current":67.646031,"twenty":22.640362,"median":38.303178,"eighty":60.799389,"marketCap":12474604533},{"date":"2024-01-26","current":70.227388,"twenty":22.677856,"median":38.50491,"eighty":61.532363,"marketCap":12950632595},{"date":"2024-02-02","current":69.19002,"twenty":22.884075,"median":38.587304,"eighty":61.916597,"marketCap":12759331598},{"date":"2024-02-09","current":69.23827,"twenty":22.890324,"median":38.625868,"eighty":62.198957,"marketCap":12768229319},{"date":"2024-02-16","current":11.82036,"twenty":22.884075,"median":38.696427,"eighty":62.821129,"marketCap":13414146195},{"date":"2024-02-23","current":12.210042,"twenty":22.58287,"median":38.613793,"eighty":62.778472,"marketCap":13856370795},{"date":"2024-03-01","current":11.942381,"twenty":22.255419,"median":38.523621,"eighty":62.312727,"marketCap":13552620565},{"date":"2024-03-08","current":11.824296,"twenty":20.664972,"median":38.430545,"eighty":62.163037,"marketCap":13418613110},{"date":"2024-03-15","current":11.749508,"twenty":15.016671,"median":38.210102,"eighty":62.021864,"marketCap":13333741722},{"date":"2024-03-22","current":11.977807,"twenty":14.597006,"median":38.097431,"eighty":61.966617,"marketCap":13592822801},{"date":"2024-03-28","current":11.98568,"twenty":14.455899,"median":37.997597,"eighty":61.934385,"marketCap":13601756631},{"date":"2024-04-05","current":11.30472,"twenty":14.395746,"median":37.829562,"eighty":61.889111,"marketCap":12828980310},{"date":"2024-04-12","current":11.434614,"twenty":14.190992,"median":37.744722,"eighty":61.843383,"marketCap":12976388510},{"date":"2024-04-19","current":10.978016,"twenty":14.097435,"median":37.720229,"eighty":61.737288,"marketCap":12458226353},{"date":"2024-04-26","current":11.170864,"twenty":13.930103,"median":37.622254,"eighty":61.590913,"marketCap":12677076753},{"date":"2024-05-03","current":11.429173,"twenty":13.857739,"median":37.494887,"eighty":61.301823,"marketCap":12970214422},{"date":"2024-05-10","current":15.790439,"twenty":13.745111,"median":37.220558,"eighty":61.104216,"marketCap":12613939409},{"date":"2024-05-17","current":15.739176,"twenty":13.753736,"median":37.112786,"eighty":60.998094,"marketCap":12573351116},{"date":"2024-05-24","current":15.157707,"twenty":13.808268,"median":34.822839,"eighty":60.858379,"marketCap":12108840655},{"date":"2024-05-31","current":14.898022,"twenty":13.852118,"median":32.773769,"eighty":60.755916,"marketCap":11901389381},{"date":"2024-06-07","current":15.331469,"twenty":13.879102,"median":32.556622,"eighty":60.617519,"marketCap":12247651204},{"date":"2024-06-14","current":15.393723,"twenty":13.894843,"median":32.486824,"eighty":60.463826,"marketCap":12297383268},{"date":"2024-06-21","current":15.071134,"twenty":13.897092,"median":32.455803,"eighty":60.288176,"marketCap":12039680751},{"date":"2024-06-28","current":15.093772,"twenty":13.904805,"median":32.339474,"eighty":60.258901,"marketCap":12057765138},{"date":"2024-07-05","current":14.669312,"twenty":13.920951,"median":32.246411,"eighty":60.178394,"marketCap":11718682879},{"date":"2024-07-12","current":15.127728,"twenty":13.960618,"median":31.928445,"eighty":60.006404,"marketCap":12084891719},{"date":"2024-07-15","current":15.150366,"twenty":13.981981,"median":31.796605,"eighty":59.980789,"marketCap":12102976106},{"date":"2024-08-02","current":16.123793,"twenty":14.003344,"median":31.734563,"eighty":59.955173,"marketCap":12880604754},{"date":"2024-08-09","current":17.406437,"twenty":14.059562,"median":31.277002,"eighty":59.651445,"marketCap":11718640189},{"date":"2024-08-16","current":18.245141,"twenty":14.081953,"median":31.218837,"eighty":59.351376,"marketCap":12283285949},{"date":"2024-08-23","current":18.458146,"twenty":14.097435,"median":31.168428,"eighty":59.252573,"marketCap":12426688047},{"date":"2024-08-30","current":19.390039,"twenty":14.125705,"median":31.141285,"eighty":59.09156,"marketCap":13054072226},{"date":"2024-09-06","current":19.350101,"twenty":14.146138,"median":31.063732,"eighty":58.974461,"marketCap":13027184332},{"date":"2024-09-13","current":18.338331,"twenty":14.160754,"median":31.005568,"eighty":58.937867,"marketCap":12346024367},{"date":"2024-09-20","current":18.631211,"twenty":14.184848,"median":30.990057,"eighty":58.879317,"marketCap":12543202252},{"date":"2024-09-27","current":18.764339,"twenty":14.243506,"median":30.904749,"eighty":58.641458,"marketCap":12632828563},{"date":"2024-10-04","current":18.471458,"twenty":14.326324,"median":30.775014,"eighty":58.287732,"marketCap":12435650679},{"date":"2024-10-11","current":18.298392,"twenty":14.368253,"median":30.610049,"eighty":58.012489,"marketCap":12319136474},{"date":"2024-10-18","current":18.67115,"twenty":14.390686,"median":30.54413,"eighty":57.699824,"marketCap":12570090145},{"date":"2024-10-25","current":18.158608,"twenty":14.408114,"median":30.465593,"eighty":57.566941,"marketCap":12225028847},{"date":"2024-10-31","current":18.098701,"twenty":14.411846,"median":30.382231,"eighty":57.528884,"marketCap":12184697007},{"date":"2024-11-08","current":10.289745,"twenty":14.406989,"median":30.354125,"eighty":57.466826,"marketCap":11782880049},{"date":"2024-11-15","current":9.925026,"twenty":14.223393,"median":30.330859,"eighty":57.444951,"marketCap":11365236488},{"date":"2024-11-22","current":10.243185,"twenty":14.10977,"median":30.171876,"eighty":57.378974,"marketCap":11729563850},{"date":"2024-11-29","current":10.344065,"twenty":14.04607,"median":30.088852,"eighty":57.232599,"marketCap":11845082282},{"date":"2024-12-06","current":10.239305,"twenty":13.894281,"median":29.997383,"eighty":57.230825,"marketCap":11725120833},{"date":"2024-12-13","current":9.781466,"twenty":13.745303,"median":29.892686,"eighty":57.217798,"marketCap":11200844873},{"date":"2024-12-20","current":9.420627,"twenty":13.663787,"median":29.795746,"eighty":57.141115,"marketCap":10787644329},{"date":"2024-12-27","current":9.855186,"twenty":13.579288,"median":29.601864,"eighty":57.126477,"marketCap":11285262189},{"date":"2025-01-03","current":10.006506,"twenty":13.531271,"median":29.389187,"eighty":57.100862,"marketCap":11458539837},{"date":"2025-01-10","current":10.165586,"twenty":13.458029,"median":29.384716,"eighty":57.078905,"marketCap":11640703518},{"date":"2025-01-17","current":12.008583,"twenty":13.264639,"median":29.284382,"eighty":57.05329,"marketCap":13751136407},{"date":"2025-01-24","current":11.880543,"twenty":13.173566,"median":29.224184,"eighty":57.011305,"marketCap":13604516859},{"date":"2025-01-31","current":12.256903,"twenty":13.053885,"median":29.19859,"eighty":56.923371,"marketCap":14035489470},{"date":"2025-02-07","current":12.183183,"twenty":12.930518,"median":29.127468,"eighty":56.889499,"marketCap":13951072155},{"date":"2025-02-14","current":16.37486,"twenty":12.913057,"median":29.097649,"eighty":56.873866,"marketCap":14065726416},{"date":"2025-02-21","current":16.813743,"twenty":12.927331,"median":28.991567,"eighty":56.853021,"marketCap":14442719083},{"date":"2025-02-28","current":16.833921,"twenty":12.943264,"median":28.872386,"eighty":56.839993,"marketCap":14460052079},{"date":"2025-03-07","current":16.788519,"twenty":12.984673,"median":28.666911,"eighty":56.830068,"marketCap":14421052838},{"date":"2025-03-14","current":16.485842,"twenty":13.031997,"median":28.143472,"eighty":56.813938,"marketCap":14161057895},{"date":"2025-03-21","current":16.899501,"twenty":13.049744,"median":27.981993,"eighty":56.738584,"marketCap":14516384317},{"date":"2025-03-28","current":15.966245,"twenty":13.070449,"median":27.828632,"eighty":56.720287,"marketCap":13714733243},{"date":"2025-04-04","current":16.03687,"twenty":13.112851,"median":27.609843,"eighty":56.720287,"marketCap":13775398729},{"date":"2025-04-11","current":15.744282,"twenty":13.135338,"median":27.489212,"eighty":56.683693,"marketCap":13524070285},{"date":"2025-04-17","current":16.238655,"twenty":13.157825,"median":27.373688,"eighty":56.63978,"marketCap":13948728691},{"date":"2025-04-25","current":16.157941,"twenty":13.203924,"median":27.227853,"eighty":56.610156,"marketCap":13879396707},{"date":"2025-05-02","current":16.384949,"twenty":13.220789,"median":27.175409,"eighty":56.605494,"marketCap":14074392914},{"date":"2025-05-09","current":13.13487,"twenty":13.220789,"median":27.160092,"eighty":56.580228,"marketCap":14343054355},{"date":"2025-05-16","current":12.773553,"twenty":13.130466,"median":27.076244,"eighty":56.544637,"marketCap":13955796159},{"date":"2025-05-23","current":12.461156,"twenty":13.066308,"median":26.904805,"eighty":56.28848,"marketCap":13614485927},{"date":"2025-05-30","current":12.588429,"twenty":12.968109,"median":26.873672,"eighty":56.212937,"marketCap":13753538244},{"date":"2025-06-06","current":13.016528,"twenty":12.90448,"median":26.797021,"eighty":56.195426,"marketCap":14221259673},{"date":"2025-06-13","current":13.602754,"twenty":12.90448,"median":26.668197,"eighty":56.189678,"marketCap":14861743072},{"date":"2025-06-20","current":13.463911,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":14710049635},{"date":"2025-06-27","current":13.602754,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":14861743072},{"date":"2025-07-03","current":14.026996,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":15325250795},{"date":"2025-07-11","current":13.930577,"twenty":12.933704,"median":26.697563,"eighty":56.189678,"marketCap":15219908130},{"date":"2025-07-18","current":13.679889,"twenty":12.997415,"median":26.697563,"eighty":56.189678,"marketCap":14946017203},{"date":"2025-07-25","current":14.111845,"twenty":13.115975,"median":26.697563,"eighty":56.189678,"marketCap":15417952339},{"date":"2025-08-01","current":14.192836,"twenty":13.181814,"median":26.697563,"eighty":56.189678,"marketCap":15506440177},{"date":"2025-08-08","current":15.6743,"twenty":13.310592,"median":26.697563,"eighty":56.189678,"marketCap":15999165780},{"date":"2025-08-15","current":15.458307,"twenty":13.437714,"median":26.697563,"eighty":56.189678,"marketCap":15778696325},{"date":"2025-08-22","current":15.37784,"twenty":13.501317,"median":26.697563,"eighty":56.189678,"marketCap":15696560645},{"date":"2025-08-29","current":15.085614,"twenty":13.602754,"median":26.697563,"eighty":56.189678,"marketCap":15398278441},{"date":"2025-09-05","current":15.627714,"twenty":13.682974,"median":26.726929,"eighty":56.189678,"marketCap":15951613545},{"date":"2025-09-12","current":15.54301,"twenty":13.727713,"median":26.697563,"eighty":56.189678,"marketCap":15865154935},{"date":"2025-09-19","current":15.132201,"twenty":13.827216,"median":26.697563,"eighty":56.189678,"marketCap":15445830676},{"date":"2025-09-26","current":14.780683,"twenty":13.857345,"median":26.697563,"eighty":56.189678,"marketCap":15087027445},{"date":"2025-10-03","current":15.454072,"twenty":13.907401,"median":26.697563,"eighty":56.189678,"marketCap":15774373394},{"date":"2025-10-10","current":15.305842,"twenty":13.996913,"median":26.697563,"eighty":56.189678,"marketCap":15623070827},{"date":"2025-10-17","current":15.390545,"twenty":14.093333,"median":26.697563,"eighty":56.189678,"marketCap":15709529437},{"date":"2025-10-24","current":15.606538,"twenty":14.18067,"median":26.697563,"eighty":56.189678,"marketCap":15929998892},{"date":"2025-10-31","current":15.644654,"twenty":14.376689,"median":26.697563,"eighty":56.189678,"marketCap":15968905267},{"date":"2025-11-07","current":22.776673,"twenty":14.487757,"median":26.697563,"eighty":56.189678,"marketCap":17423152601},{"date":"2025-11-14","current":22.190221,"twenty":14.585763,"median":26.697563,"eighty":56.189678,"marketCap":16974542737},{"date":"2025-11-21","current":21.441797,"twenty":14.71386,"median":26.697563,"eighty":56.189678,"marketCap":16402031102},{"date":"2025-11-28","current":22.352193,"twenty":14.852999,"median":26.697563,"eighty":56.189678,"marketCap":17098444509},{"date":"2025-12-05","current":21.866276,"twenty":14.925958,"median":26.697563,"eighty":56.189678,"marketCap":16726739194},{"date":"2025-12-12","current":21.676378,"twenty":15.032381,"median":26.697563,"eighty":56.189678,"marketCap":16581475048},{"date":"2025-12-19","current":21.464138,"twenty":15.093897,"median":26.697563,"eighty":56.189678,"marketCap":16419121002},{"date":"2025-12-26","current":21.922129,"twenty":15.149631,"median":26.697563,"eighty":56.189678,"marketCap":16769463943},{"date":"2026-01-02","current":21.581428,"twenty":15.187258,"median":26.697563,"eighty":56.189678,"marketCap":16508842974},{"date":"2026-01-09","current":22.48624,"twenty":15.23808,"median":26.697563,"eighty":56.189678,"marketCap":17200983907},{"date":"2026-01-16","current":22.184636,"twenty":15.252479,"median":26.697563,"eighty":56.189678,"marketCap":16970270263},{"date":"2026-01-23","current":22.402461,"twenty":15.277931,"median":26.697563,"eighty":56.189678,"marketCap":17136896783},{"date":"2026-01-30","current":22.821355,"twenty":15.310924,"median":26.697563,"eighty":56.189678,"marketCap":17457332400},{"date":"2026-02-06","current":24.630978,"twenty":15.328798,"median":26.697563,"eighty":56.189678,"marketCap":18841614264},{"date":"2026-02-13","current":24.895555,"twenty":15.360052,"median":26.697563,"eighty":56.189678,"marketCap":19193153817},{"date":"2026-02-20","current":25.067824,"twenty":15.379534,"median":26.630837,"eighty":56.189678,"marketCap":19325963587},{"date":"2026-02-27","current":25.20675,"twenty":15.379534,"median":26.529015,"eighty":56.189678,"marketCap":19433068240},{"date":"2026-03-06","current":25.384575,"twenty":15.379534,"median":26.382064,"eighty":56.189678,"marketCap":19570162196},{"date":"2026-03-13","current":25.490159,"twenty":15.379534,"median":26.335729,"eighty":56.189678,"marketCap":19651561732},{"date":"2026-03-20","current":25.30122,"twenty":15.379534,"median":26.159501,"eighty":56.189678,"marketCap":19505899404},{"date":"2026-03-26","current":26.134776,"twenty":15.379534,"median":26.092243,"eighty":56.189678,"marketCap":20148527322}],"updateTime":1774676606414},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RPRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622007603","title":"Royalty Pharma; EVP & CFO Terrance P. Coyne reports common share disposal valued at $1,583,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007603","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007603?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:06","pubTimestamp":1774472768,"startTime":"0","endTime":"0","summary":"Terrance Coyne, EVP and CFO of Royalty Pharma, reported sales of Class A ordinary shares on 03/23/2026.32,916 shares were sold at a weighted average price of USD 45.53 per share.An additional 1,875 shares were sold at a weighted average price of USD 45.53 per share.Following the transactions, 65,832 shares were beneficially owned indirectly through TPC RP 2021.Indirect holdings also included 43,886 shares through TPC RP EPA1.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsible for the i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDLccX4gr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma; EVP & CFO Terrance P. Coyne reports common share disposal valued at $1,583,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2622502011","title":"How Royalty Pharma’s New AI and Dealmaking Hires Could Shape RPRX’s Royalty Sourcing Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2622502011","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622502011?lang=en_us&edition=fundamental","pubTime":"2026-03-25 06:13","pubTimestamp":1774390429,"startTime":"0","endTime":"0","summary":"Royalty Pharma has recently strengthened its leadership bench, appointing former IQVIA technology leader Lucas Glass as Head of Artificial Intelligence and bringing in Greg Butz from Bank of America as Executive Vice President, Partnering & Investments, alongside elevating Chris Hite to Chairman, Partnering & Investments and expanding its regional leadership with a new Head of Asia.\nThese hires point to a company-wide push to embed artificial intelligence into decision-making and broaden...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/how-royalty-pharmas-new-ai-and-dealmaking-hires-could-shape","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rprx/royalty-pharma/news/how-royalty-pharmas-new-ai-and-dealmaking-hires-could-shape","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4588","AIYY","BK4543","BK4587","AI","BK4551","BK4528","RPRX","BK4007","BK4023"],"gpt_icon":0},{"id":"2621705857","title":"Press Release: Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence","url":"https://stock-news.laohu8.com/highlight/detail?id=2621705857","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621705857?lang=en_us&edition=fundamental","pubTime":"2026-03-23 19:15","pubTimestamp":1774264500,"startTime":"0","endTime":"0","summary":"NEW YORK, March 23, 2026  -- Royalty Pharma plc  today announced the appointment of Lucas Glass as Head of Artificial Intelligence, effective April 2026. Lucas will lead the development and implementation of artificial intelligence capabilities across Royalty Pharma.\"Lucas's appointment marks a significant step in our commitment to implementing cutting--edge technology across our platform,\" said Pablo Legorreta, Chief Executive Officer and Chairman of the Board of Royalty Pharma. \"By incorporating intelligent automation, advanced analytics and AI-driven decision support, we are strengthening how we evaluate and invest in royalties and support our partners. Lucas brings more than a decade of experience building enterprise-scale AI and data solutions in life sciences and his work will enhance Royalty Pharma's competitive advantage through more informed decision-making and improved efficiency across the firm.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2620473818","title":"S&P 500 Futures Decline In Premarket Trading; Super Micro Computer, Royalty Pharma Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2620473818","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620473818?lang=en_us&edition=fundamental","pubTime":"2026-03-20 19:31","pubTimestamp":1774006260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Planet Labs PBC  was up 15.9% in pre-market trading, and FedEx Corp.  was up 8.1%.Rhythm Pharmaceuticals Inc. , Super Group  Ltd. , and Dell Technologies Inc. Cl C  were all posting gains of at least 3%. In early trading, Super Micro Computer Inc.  and Royalty Pharma PLC  had posted declines, falling 26.5% and 6.7%, respectively.Meanwhile S&P 500 futures were down 0.36%, with futures for the Dow Jones Industrial Average falling 0.27%. The Cboe Volatility Index futures were down 4.22%.In commodities news, Brent crude oil futures were down 0.60%, while gold futures were up 1.39%. Bitcoin was up 0.63% to $70,704.In the previous regular trading session, the S&P 500 and the Dow were down 0.27% and 0.44%, respectively. In Asia overnight, China's Shanghai Composite Index was down 1.24%.U.S. stock markets open for trading at 9:30 a.m. ET.Data source","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMCX","RPRX","SPDN","DLLL","SDS","VTV","OEF","MESmain","SPLV","RSP","IVV",".SPX","SMYY","SGHC","ESmain","SPYI","JEPI","SPYG","SMCL","PLU","BMAY","VOO","SMCZ","SSO","DELL","FDX","SPXU","SCHG","IVOO","RYTM","XDTE","SPYV","VTI","OEX","VYM","XYLD","SMCY","SPMO","UPRO","VUG","SPXL","VOOG","SPY","HIBL","SMCI","GPIX","SH","IVW","SMCC"],"gpt_icon":1},{"id":"2620088544","title":"Press Release: Royalty Pharma Announces Expansion of Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2620088544","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620088544?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:01","pubTimestamp":1773777660,"startTime":"0","endTime":"0","summary":"NEW YORK, March 17, 2026  -- Royalty Pharma plc  today announced an expansion of its leadership team. Greg Butz will join Royalty Pharma as Executive Vice President, Partnering & Investments, effective June 2026. Greg joins Royalty Pharma from Bank of America, where he was the Global Co-Head of Healthcare Investment Banking.Greg Butz joins Royalty Pharma from Bank of America where he served as Global Co-Head of Healthcare Investment Banking. At Bank of America, Greg worked with public and private biopharma companies across a range of capital raising and strategic advisory transactions. Prior to his acting as Global Co-Head of Healthcare, Greg held Co-Head North American Healthcare Investment Banking and Head of Life Sciences I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4553","LU1280957306.USD","LU0640476718.USD","LU0256863811.USD","LU0310800965.SGD","BAC","LU1894683264.USD","RPRX","IE00BKVL7J92.USD","LU1267930227.SGD","IE00BLSP4239.USD","LU0868494617.USD","LU1894683348.USD","LU0052756011.USD","LU0314106906.USD","LU1506573853.SGD","LU0971096721.USD","LU0149725797.USD","LU0130518102.USD","LU0648001328.SGD","LU0130102774.USD","LU1074936037.SGD","LU0234572021.USD","TISI","IE00B7SZLL34.SGD","LU0128525689.USD","LU0320765489.SGD","IE00BZ1G4Q59.USD","LU2129689514.USD","LU0130517989.USD","IE0001KFT4U8.USD","LU0170899867.USD","LU2129689431.USD","BK4120","BK4559","BK4504","BK4007","BK4581","LU1804176565.USD","LU0417517546.SGD","LU1496350502.SGD","LU0321505439.SGD","BK4534","LU1035773651.USD","LU2133065610.SGD","LU0787776722.HKD","LU2129689605.HKD","LU1069347547.HKD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2617647945","title":"Royalty Pharma EVP and CFO Terrance P. Coyne Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2617647945","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617647945?lang=en_us&edition=fundamental","pubTime":"2026-03-05 06:12","pubTimestamp":1772662352,"startTime":"0","endTime":"0","summary":"Terrance P. Coyne, EVP and CFO of Royalty Pharma plc, reported a disposal of the company’s Class A ordinary shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL6DLTd0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma EVP and CFO Terrance P. Coyne Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0},{"id":"2616331873","title":"Press Release: Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2616331873","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616331873?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:01","pubTimestamp":1772452860,"startTime":"0","endTime":"0","summary":"NEW YORK, March 02, 2026  -- Royalty Pharma plc  today announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty business in Asia. Ken joins Royalty Pharma from Morgan Stanley, where he was Head of Asia Pacific Healthcare Investment Banking.In his previous role as Managing Director, Head of Asia Pacific Healthcare Investment Banking at Morgan Stanley, Ken led the establishment of the bank's leadership position in China. He advised a diverse spectrum of strategic clients, including biotech, medtech, CRO, pharmaceutical and healthcare service companies. Ken successfully led origination and execution of notable and industry defining healthcare transactions across IPOs, M&A, and biotech licensing advisory, with a primary focus on Greater China. He brings more than 18 years of investment banking experience, having previously worked at China Renaissance and BNP Paribas. Ken holds a Bac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0098860793.USD","LU0158827781.USD","LU0912757837.SGD","LU1244550577.SGD","LU0882574139.USD","LU1668664300.SGD","BK4585","BK4504","LU0234570918.USD","LU0795875169.SGD","LU1720051108.HKD","LU2089283258.USD","BK4534","LU0971096721.USD","LU1732799900.SGD","LU1989772840.SGD","LU1162221912.USD","RPRX","LU1791710400.SGD","BK4127","BK4007","LU0106831901.USD","LU1244550221.USD","LU1244550494.USD","LU1989772923.USD","LU2028103732.USD","LU1791710582.SGD","BK4516","LU2023251221.USD","LU1363072403.SGD","LU0528227936.USD","LU0267386448.USD","LU1720051017.SGD","IE00BKVL7J92.USD","LU1074936037.SGD","LU0314104364.USD","LU0320765646.SGD","LU2089284900.SGD","BK4581","LU1548497426.USD","LU2133065610.SGD","LU0225283273.USD","LU0158827948.USD","LU2271345857.HKD","LU0795875086.SGD","LU0106261372.USD","LU0557290698.USD","LU1732800096.USD","LU0006306889.USD"],"gpt_icon":0},{"id":"2616766336","title":"Zymeworks Q4 Net Loss Widens, Revenue Falls; Enters $250 Million Financing Agreement with Royalty Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2616766336","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616766336?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:35","pubTimestamp":1772451309,"startTime":"0","endTime":"0","summary":"Zymeworks  reported a Q4 net loss Monday of $0.55 per diluted share, widening from a loss of $0.31 a year earlier.Analysts polled by FactSet expected a loss of $0.46.Revenue for the quarter ended Dec. 31 was $2.5 million, compared with $31 million a year earlier.Analysts surveyed by FactSet expected $19.2 million.As of Dec. 31, the company said it had $270.6 million in cash, cash equivalents and marketable securities, which it expects to fund operations beyond 2028.Additionally, Royalty Pharma  and Zymeworks  said Monday the companies have entered into a $250 million non-recourse royalty-backed note financing, with repayments tied to 30% of Zymeworks' worldwide tiered royalties on Ziihera.Under the agreement, Zymeworks will retain 70% of royalties from Ziihera sales during the repayment period, with full royalty rights reverting to the company once Royalty Pharma receives agreed cumulative payments, the companies said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4139","RPRX","ZYME"],"gpt_icon":0},{"id":"2616335080","title":"Zymeworks, Royalty Pharma enter $250M royalty-backed note financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335080","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335080?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:15","pubTimestamp":1772450110,"startTime":"0","endTime":"0","summary":"Zymeworks (ZYME) and Royalty Pharma (RPRX) announced an agreement for $250M in funding from Royalty Pharma in the form of a non-recourse royalty-ba...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zymeworks-royalty-pharma-enter-250m-royalty-backed-note-financing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zymeworks-royalty-pharma-enter-250m-royalty-backed-note-financing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZYME","BK4139","RPRX","BK4007"],"gpt_icon":0},{"id":"2616335665","title":"Canada's Zymeworks 2025 revenue rises 39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335665","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335665?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:08","pubTimestamp":1772449711,"startTime":"0","endTime":"0","summary":"Canada's Zymeworks 2025 revenue rises 39%OverviewBiotechnology firm's 2025 revenue rose 39% yr/yr, driven by clinical milestonesNet loss for 2025 reduced by 34% compared to previous yearCompany utiliz","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL1N3ZQ0EU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","ZYME","BK4007","BK4139"],"gpt_icon":0},{"id":"2616335813","title":"Zymeworks and Royalty Pharma Enter Into $250 Million Royalty-Backed Note Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335813","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335813?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:01","pubTimestamp":1772449287,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ0K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RPRX","BK4139","ZYME"],"gpt_icon":0},{"id":"2616335336","title":"Zymeworks Inc - Co to Retain 70% of Ziihera Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335336?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:01","pubTimestamp":1772449287,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ0K6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZYME","BK4139","BK4007","RPRX"],"gpt_icon":0},{"id":"2616335363","title":"Zymeworks Secures $250 Million Royalty-Backed Note Financing From Royalty Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2616335363","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616335363?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:01","pubTimestamp":1772449285,"startTime":"0","endTime":"0","summary":"Zymeworks Inc. has entered a $250 million non-recourse royalty-backed note financing with Royalty Pharma. Repayment will come from 30% of Zymeworks’ worldwide tiered royalties on Ziihera owed by partners Jazz Pharmaceuticals and BeOne Medicines until Royalty Pharma receives up to specified repayment caps, after which full royalty rights revert to Zymeworks. Zymeworks will retain the remaining 70% of royalties during the repayment period and said the non-dilutive proceeds will support share repurchases, potential acquisitions and extend its cash runway beyond 2028.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL5N25fd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0154245756.USD","RPRX","SG9999014005.SGD","LU2210150020.SGD","LU2095319765.USD","BK4007","BK4139","BK4585","SG9999014013.SGD","NDAQ","BK4532","BK4533","BK4588","IE00BN0W2W23.USD","LU0823416689.USD","ZYME","SG9999014039.USD","IE00BKPKM429.USD","BK4112","IE00BN0W2V16.EUR","LU0889565916.HKD","LU0314104364.USD","LU2210149790.SGD","LU0154245673.USD","SG9999014021.USD","IE00BN0W2T93.GBP","JAZZ","LU0109394709.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2616353603","title":"Zymeworks FY 2025 revenue rises 39% to USD 106.0 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2616353603","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616353603?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:01","pubTimestamp":1772449278,"startTime":"0","endTime":"0","summary":"Zymeworks  reported FY 2025 total revenue of USD 106.0 million, up 39%, and a FY net loss of USD 81.1 million, down 34%. In Q4 2025, revenue was USD 2.5 million and net loss was USD 41.2 million. FY 2025 R&D expenses were USD 137.0 million and G&A expenses were USD 61.5 million. Zymeworks ended 2025 with USD 270.6 million in cash, cash equivalents and marketable securities. On the business side, partner Jazz expects to complete a supplemental BLA for Ziihera in first-line HER2-positive gastroesophageal adenocarcinoma in Q1 2026 in the U.S., with a potential launch in H2 2026. Zymeworks said it is eligible for up to USD 440.0 million in regulatory milestones tied to Ziihera approvals in GEA across the U.S., Europe, Japan and China, and noted tiered royalties with Jazz and BeOne. The company also announced a USD 250.0 million non-recourse royalty-backed note financing with Royalty Pharma and said it had used USD 62.5 million of its USD 125.0 million share repurchase authorization as of M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLbqk5yH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4588","IE00BKPKM429.USD","SG9999014013.SGD","NDAQ","LU0314104364.USD","BK4139","IE00B3QW5Z07.USD","SG9999014039.USD","RPRX","LU2210150020.SGD","LU2095319765.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4585","BK4007","SG9999014005.SGD","BK4112","ZYME","LU2210149790.SGD"],"gpt_icon":0},{"id":"2614071650","title":"Royalty Pharma to Join Fireside Chat at TD Cowen 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2614071650","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614071650?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:40","pubTimestamp":1772142035,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDLc58k9x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2614056501","title":"Royalty Pharma EVP and CFO Terrance P. Coyne Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614056501","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614056501?lang=en_us&edition=fundamental","pubTime":"2026-02-26 05:09","pubTimestamp":1772053776,"startTime":"0","endTime":"0","summary":"Terrance P. Coyne, EVP and CFO of Royalty Pharma plc, reported a disposal of Class A ordinary shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 25, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDLc3dkMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Royalty Pharma EVP and CFO Terrance P. Coyne Disposes of Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RPRX"],"gpt_icon":0},{"id":"2614550900","title":"RevMed Q4 net loss widens to USD 364.9 million (87.5%)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614550900","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614550900?lang=en_us&edition=fundamental","pubTime":"2026-02-26 05:04","pubTimestamp":1772053470,"startTime":"0","endTime":"0","summary":"RevMed Q4 net loss widens to USD 364.9 million (87.5%)               Revolution Medicines (RVMD) reported a Q4 net loss of USD 364.9 million and a FY 2025 net loss of USD 1.1 billion. Q4 R&D expenses ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDLxwgNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4588","LU2095319765.USD","NDAQ","SG9999014013.SGD","BK4007","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD","BK4139","RPRX","LU0314104364.USD","BK4585","BK4112","LU2210149790.SGD","IE00BKPKM429.USD","IE00B64PRP62.GBP","RVMD","SG9999014039.USD"],"gpt_icon":0},{"id":"2614877051","title":"BRAIN Biotech posts Q1 net loss of EUR 2.9 million, revenue down 9% to EUR 11.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614877051","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614877051?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:30","pubTimestamp":1772001047,"startTime":"0","endTime":"0","summary":"BRAIN Biotech reported Q1 FY 2025/26 revenue of EUR 11.9 million, down 9.0%, with total operating performance of EUR 13.0 million. Adjusted EBITDA was EUR 0.3 million, while EBITDA was EUR -0.3 million and EBIT was EUR -1.5 million. Net loss for the period was EUR 2.9 million, with EPS  of EUR -0.13. In BRAINBiocatalysts, Q1 revenue was EUR 10.0 million  and adjusted EBITDA was EUR 0.5 million, with the company citing low sales momentum in baking enzymes and production interruptions tied to the relocation of production facilities to a new joint site in the Netherlands. BRAINBioIncubator Q1 revenue was EUR 1.9 million, supported by a EUR 1.0 million milestone payment related to the deucrictibant project; the company also noted that license and monetization agreements with Pharvaris and Royalty Pharma have generated EUR 3.3 million in milestone payments so far in FY 2025/26, including EUR 2.3 million received as cash inflow in Q1. Cash and cash equivalents were EUR 5.1 million at 31 Dece","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL5DmRdQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS","RPRX"],"gpt_icon":0},{"id":"2612238369","title":"PTC Therapeutics posts FY 2025 total revenues of USD 1.73B**2.15x**","url":"https://stock-news.laohu8.com/highlight/detail?id=2612238369","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612238369?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:02","pubTimestamp":1771534932,"startTime":"0","endTime":"0","summary":"PTC Therapeutics posts FY 2025 total revenues of USD 1.73B**2.15x**               PTC Therapeutics reported Q4 2025 total revenues of USD 164.7 million (-22.8%) and total net product revenues of USD 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL6gmjDl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","PTCT","BK4139","BK4007"],"gpt_icon":0},{"id":"2612468672","title":"Royalty Pharma plc Publishes Q4 2025 Financial Results Call Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2612468672","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612468672?lang=en_us&edition=fundamental","pubTime":"2026-02-17 22:36","pubTimestamp":1771338996,"startTime":"0","endTime":"0","summary":"Royalty Pharma plc has published the transcript of its Q4 2025 financial results conference call, held on February 11, 2026. The event was attended by key company executives including the Founder & Chief Executive Officer, the Chief Financial Officer, the Vice Chairman, and the Executive Vice President of Research & Investments, alongside several analysts from major financial institutions. During the call, management discussed the company's fourth-quarter and full-year 2025 financial results, highlighting the strength of their development-stage portfolio and the anticipated impact of upcoming data. The CEO noted, “It does highlight the incredible potential of our development-stage portfolio. We're really excited to see this.” He added, “After waiting a few years at this point for this event, as you might imagine, we are eager to see it and discuss the data with everybody.” The full transcript can be accessed through the link below.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL300PNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RPRX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":97,"code":"91000000","status":"200"}]}}